Paediatric Haematology Research Unit
101 – 110 of 271
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.
- Contribution to journal › Article
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
- Contribution to journal › Article
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
- Contribution to journal › Article
-
Mark
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
- Contribution to journal › Article
-
Mark
Hemophilia and prophylaxis.
- Contribution to journal › Scientific review
- 2012
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
- Contribution to journal › Article
-
Mark
Beyond patient benefit: clinical development in hemophilia
- Contribution to journal › Scientific review
-
Mark
Origin of Swedish hemophilia A mutations
- Contribution to journal › Article
-
Mark
Optimizing joint function : new knowledge and novel tools and treatments
- Contribution to journal › Article
-
Mark
Konstitutionella anemier
(2012) p.241-253
- Chapter in Book/Report/Conference proceeding › Book chapter
